Skip to main content
Log in

Transcatheter Closure of Atrial Septal Defects using the GORE® Septal Occluder in Children Less Than 10 kg of Body Weight

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

The GORE® Septal Occluder (GSO) is a well-evaluated device for interventional ASD closure with closure rates comparable to the Amplatzer® Septal Occluder (ASO), but there are no published reports of its use in small children weighing less than 10 kg. This may be due to the necessity of a large-sized introducing sheath of at least 10 Fr and therefore the assumed risk of complications in vascular access. The GSO is an alternative option for interventional ASD closure in children weighing less than 10 kg. Fourteen infants and children with a median body weight 8900 g (range 6350–9650 g) underwent successful ASD closure using the GSO. The closure was performed under fluoroscopic and transthoracic echocardiographic guidance. Postprocedure, the vessels passed by the occluder and delivery catheter were examined by duplex sonography. The median ASD diameter was 11 mm (5–17 mm), and the median GSO size was 22.5 mm (15–30 mm), whereas the median ASO left disc size that would have been recommended was 25 mm (17–31 mm). All ASDs were successfully closed. During a median follow-up of 1.57 years (range 0.5–4.2), no complications like erosion, embolization, arrhythmias, or vascular injuries occurred. Although using a 10-Fr introducer sheath, no vascular complications were detected. Our data suggest that the small usable size as well as the soft and flexible design of the device allows successful use of the GSO in young children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Agnoletti G et al (2005) Complications of paediatric interventional catheterisation: an analysis of risk factors. Cardiol Young 15(4):402–408

    Article  PubMed  Google Scholar 

  2. Amin Z (2014) Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement. Catheter Cardiovasc Interv 83(1):84–92

    Article  PubMed  Google Scholar 

  3. Amin Z et al (2004) Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 63(4):496–502

    Article  PubMed  Google Scholar 

  4. Amplatzer Medical Corporation, Septal Occluder and delivery system. 2007. http://manuals.sjm.com/Search-Form?re=North-America&cc=US&ln=all&fam=db52be0a-e057-428d-9897-67e1e67f542e&cat=71260c89-7cb8-475d-950b-0262191e7526&seg=dd28d64f-7d0b-4660-aa2c-da987bb7894c&ipp=10

  5. Andrews R et al (2002) Atrial septal defect with failure to thrive in infancy: hidden pulmonary vascular disease? Pediatr Cardiol 23(5):528–530

    Article  PubMed  Google Scholar 

  6. Bartakian S et al (2013) Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the Amplatzer septal occluder. JACC Cardiovasc Interv 6(9):974–980

    Article  PubMed  Google Scholar 

  7. Behjati-Ardakani M, Sadr-Bafghi SM, Andishmand A (2012) Combined transcatheter closure of atrial septal defect and pulmonary valve balloon dilation. Acta Med Iran 50(10):710–712

    PubMed  Google Scholar 

  8. Bishnoi RN et al (2014) Device closure of secundum atrial septal defects in infants weighing less than 8 kg. Pediatr Cardiol 35(7):1124–1131

    Article  PubMed  Google Scholar 

  9. Crawford GB et al (2012) Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature. Catheter Cardiovasc Interv 80(2):157–167

    Article  PubMed  Google Scholar 

  10. El-Said H et al (2015) Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv 85(2):227–233

    Article  PubMed  Google Scholar 

  11. Erdem A et al (2013) Transthoracic echocardiographic guidance during transcatheter closure of atrial septal defects in children and adults. Int J Cardiovasc Imaging 29(1):53–61

    Article  PubMed  Google Scholar 

  12. Grohmann J et al (2014) Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE(R) septal occluder. Catheter Cardiovasc Interv 84(6):E51–E57

    Article  CAS  PubMed  Google Scholar 

  13. Javois AJ et al (2014) Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect. JACC Cardiovasc Interv 7(8):905–912

    Article  PubMed  Google Scholar 

  14. Kazmouz S et al (2013) Transcatheter closure of secundum atrial septal defects. J Invasive Cardiol 25(5):257–264

    PubMed  Google Scholar 

  15. Kin H et al (1997) Effects of balloon pulmonary valvuloplasty on atrial shunting–a patient with pulmonary valve stenosis and a large secundum atrial septal defect. Jpn Circ J 61(2):192–196

    Article  CAS  PubMed  Google Scholar 

  16. Knop M et al (2014) Transcatheter closure of atrial septal defect in children up to 10 kg of body weight with Amplatzer device. Cardiol J 21(3):279–283

    Article  PubMed  Google Scholar 

  17. Kutty S et al (2012) Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect. Am J Cardiol 109(9):1348–1352

    Article  PubMed  Google Scholar 

  18. Lammers A et al (2005) Need for closure of secundum atrial septal defect in infancy. J Thorac Cardiovasc Surg 129(6):1353–1357

    Article  PubMed  Google Scholar 

  19. Lo MH et al (2011) Impact of transcatheter closure of atrial septal defects in pediatric patients on body weight. J Formos Med Assoc 110(7):467–472

    Article  PubMed  Google Scholar 

  20. Miga DE et al (1997) Incidence of femoral vein occlusion after catheter ablation in children: evaluation with magnetic resonance angiography. Pediatr Cardiol 18(3):204–207

    Article  CAS  PubMed  Google Scholar 

  21. Monfredi O et al (2013) Percutaneous device closure of atrial septal defect results in very early and sustained changes of right and left heart function. Int J Cardiol 167(4):1578–1584

    Article  PubMed  Google Scholar 

  22. Nakasato M et al (1997) Balloon pulmonary valvuloplasty for pulmonary valve stenosis with atrial septal defect. Am J Cardiol 79(6):838–839

    Article  CAS  PubMed  Google Scholar 

  23. Nyboe C, Hjortdal VE, Nielsen-Kudsk JE (2013) First experiences with the GORE((R)) septal occluder in children and adults with atrial septal defects. Catheter Cardiovasc Interv 82(6):929–934

    Article  PubMed  Google Scholar 

  24. Pawelec-Wojtalik M et al (2006) Comparison of cardiac function in children after surgical and Amplatzer occluder closure of secundum atrial septal defects. Eur J Cardiothorac Surg 29(1):89–92

    Article  PubMed  Google Scholar 

  25. Rhodes JF Jr, Goble J (2014) Combined prospective United States clinical study data for the GORE((R)) HELEX((R)) septal occluder device. Catheter Cardiovasc Interv 83(6):944–952

    Article  PubMed  Google Scholar 

  26. Smith B et al (2014) UK multicenter experience using the gore septal occluder (GSO(TM)) for atrial septal defect closure in children and adults. Catheter Cardiovasc Interv 83(4):581–586

    Article  PubMed  Google Scholar 

  27. Thomas VC et al (2012) Transcatheter closure of secundum atrial septal defect in infants less than 12 months of age improves symptoms of chronic lung disease. Congenit Heart Dis 7(3):204–211

    Article  PubMed  Google Scholar 

  28. U.S. Food and Drug Administration, Rare Serious Erosion Events Associated with St. Jude Amplatzer Atrial Septal Occluder (ASO): FDA Safety Communication. 2013 10.10.2015. http://www.fda.gov/medicaldevices/safety/Alertsandnotices/ucm371145.htm

  29. Vitiello R et al (1998) Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 32(5):1433–1440

    Article  CAS  PubMed  Google Scholar 

  30. Wood AM et al (2011) Transcatheter elimination of left-to-right shunts in infants with bronchopulmonary dysplasia is feasible and safe. Congenit Heart Dis 6(4):330–337

    Article  PubMed  Google Scholar 

  31. Zanjani KS et al (2011) Transcatheter atrial septal defect closure under transthorasic echocardiography in children. Iran J Pediatr 21(4):473–478

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tariq Abu-Tair.

Ethics declarations

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Appendix: Products

Appendix: Products

Amplatzer® Cribriform Occluder

St. Jude Medical® Inc.

Amplatzer® Septal Occluder

St. Jude Medical® Inc.

GORE® HELEX® Septal Occluder

W. L. Gore & Associates, Inc., Medical Products Division

GORE® Septal Occluder

W. L. Gore & Associates, Inc., Medical Products Division Renamed in June 2015 to “GORE® CARDIOFORM Septal Occluder”

Terumo® Introducer

Terumo® Europe N.V.

V-18™ Control Wire™

Boston Scientific

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abu-Tair, T., Wiethoff, C.M., Kehr, J. et al. Transcatheter Closure of Atrial Septal Defects using the GORE® Septal Occluder in Children Less Than 10 kg of Body Weight. Pediatr Cardiol 37, 778–783 (2016). https://doi.org/10.1007/s00246-016-1350-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-016-1350-6

Keywords

Navigation